A pharmaceutical company conducts a clinical trial to test the efficacy of a novel cancer therapy. The company randomly selects 15 subjects from a larger population of patients with relapsed and refractory diffuse large b-cell lymphoma. Each subject is randomly assigned to one of three treatment groups. Within each treatment group, subjects receive a different dose of the new medication. G1 subjects receive 0mg/day, G2 subjects receive 50mg/day and G3 subjects receive 100mg/day. The doctors measure the lesion sizes in each subject. Results are as below. Assume 0.05 level. Group 1 Group 2 Group 3 89 819 953 911 575 224 967 69 463 290 418 200 312 880 529
A pharmaceutical company conducts a clinical trial to test the efficacy of a novel cancer therapy. The company randomly selects 15 subjects from a larger population of patients with relapsed and refractory diffuse large b-cell lymphoma. Each subject is randomly assigned to one of three treatment groups. Within each treatment group, subjects receive a different dose of the new medication. G1 subjects receive 0mg/day, G2 subjects receive 50mg/day and G3 subjects receive 100mg/day. The doctors measure the lesion sizes in each subject. Results are as below. Assume 0.05 level.
|
Group 1 |
Group 2 |
Group 3 |
|
89 |
819 |
953 |
|
911 |
575 |
224 |
|
967 |
69 |
463 |
|
290 |
418 |
200 |
|
312 |
880 |
529 |
What is the SS BETWEEN? Round to the nearest tenth.
What is DF BETWEEN?
Does the dosage level have a significant effect on the lesion measurements?
Trending now
This is a popular solution!
Step by step
Solved in 2 steps with 1 images
